M. Alter, D. Kruszon-moran, O. Nainan, G. Mcquillan, F. Gao et al., The prevalence of hepatitis C virus infection in the United States Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease, N Engl J Med MMWR Recomm Rep, vol.341, issue.47, pp.556-5621, 1988.

J. Evans, J. Hahn, K. Page-shafer, P. Lum, E. Stein et al., Gender Differences in Sexual and Injection Risk Behavior Among Active Young Injection Drug Users in San Francisco (the UFO Study), Journal of Urban Health: Bulletin of the New York Academy of Medicine, vol.80, issue.1, pp.137-146, 2003.
DOI : 10.1093/jurban/jtg137

D. Prithwish, E. Roy, J. Boivin, J. Cox, and C. Morissette, Risk of hepatitis C virus transmission through drug preparation equipment: a systematic review, J Viral Hepat, vol.15, pp.279-92, 2008.

K. Stark, R. Muller, and U. Bienzle, Frontloading, AIDS, vol.10, issue.3, pp.311-317, 1996.
DOI : 10.1097/00002030-199603000-00010

C. Mccoy, L. Metsch, D. Chitwood, P. Shapshak, and S. Comerford, Parenteral Transmission of HIV Among Injection Drug Users: Assessing the Frequency of Multiperson Use of Needles, Syringes, Cookers, Cotton, and Water, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.18, issue.1, pp.18-25, 1998.
DOI : 10.1097/00042560-199802001-00006

H. Hagan, H. Thiede, N. Weiss, S. Hopkins, J. Duchin et al., Sharing of drug preparation equipment as a risk factor for hepatitis C, Am J Public Health, vol.91, pp.42-46, 2001.

C. Mathei, Z. Shkedy, B. Denis, C. Kabali, M. Aerts et al., Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users, Journal of Viral Hepatitis, vol.8, issue.6, pp.560-570, 2006.
DOI : 10.1002/jmv.20212

M. Zwahlen and D. Vlahov, Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users, International Journal of Epidemiology, vol.32, issue.5, pp.715-716, 2003.
DOI : 10.1093/ije/dyg169

J. Murray, M. Law, Z. Gao, and J. Kaldor, The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users, International Journal of Epidemiology, vol.32, issue.5, pp.708-714, 2003.
DOI : 10.1093/ije/dyg102

C. Miller, C. Johnston, P. Spittal, K. Li, N. Laliberte et al., Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users, Hepatology, vol.93, issue.3, pp.737-742, 2002.
DOI : 10.1053/jhep.2002.35065

J. Hahn, K. Page-shafer, P. Lum, P. Bourgois, E. Stein et al., Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks, The Journal of Infectious Diseases, vol.186, issue.11, pp.1558-1564, 2002.
DOI : 10.1086/345554

D. Moore and S. Fraser, Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications, Social Science & Medicine, vol.62, issue.12, pp.3035-3047, 2006.
DOI : 10.1016/j.socscimed.2005.11.067

G. Marlatt, Harm reduction: pragmatic strategies for managing high-risk behaviours, 1998.

J. Kleinig, Ethical Issues in Substance Use Intervention, Substance Use & Misuse, vol.64, issue.1, pp.369-398, 2004.
DOI : 10.1081/JA-120029983

M. Jauffret-roustide, Les drogues: approche sociologique, économique et politique Paris: La Documentation Française, 2004.

D. Jarlais, D. Friedman, and S. , Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done, Public Health Rep, vol.113, issue.1, pp.182-188, 1998.

S. Villano, D. Vlahov, K. Nelson, C. Lyles, S. Cohn et al., Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland, J Clin Microbiol, vol.35, pp.3274-3277, 1997.

L. Strasfeld, Y. Lo, D. Netski, D. Thomas, and R. Klein, The Association of Hepatitis C Prevalence, Activity, and Genotype With HIV Infection in a Cohort of New York City Drug Users, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.33, issue.3, pp.356-364, 2003.
DOI : 10.1097/00126334-200307010-00010

K. Roy, S. Hutchinson, S. Wadd, A. Taylor, S. Cameron et al., Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them, Epidemiology and Infection, vol.135, issue.03, pp.433-442, 2007.
DOI : 10.1017/S0950268806007035

C. Mathei, F. Buntinx, and P. Van-damme, Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review, Journal of Viral Hepatitis, vol.30, issue.3, pp.157-173, 2002.
DOI : 10.1002/hep.510290442

L. Maher, B. Jalaludin, K. Chant, R. Jayasuriya, T. Sladden et al., Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia, Addiction, vol.26, issue.10, pp.1499-1508, 2006.
DOI : 10.1111/j.1360-0443.2006.01543.x

L. Hwang, J. Kramer, C. Troisi, L. Bull, C. Grimes et al., Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population, Hepatology, vol.11, issue.2, pp.341-351, 2006.
DOI : 10.1002/hep.21252

T. Diaz, D. Jarlais, D. Vlahov, D. Perlis, T. Edwards et al., Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, Am J Public Health, vol.91, pp.23-30, 2001.

M. Backmund, J. Reimer, K. Meyer, J. Gerlach, and R. Zachoval, Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment, Clinical Infectious Diseases, vol.40, issue.s5, pp.40-330, 2005.
DOI : 10.1086/427475

N. Crofts, D. Jolley, J. Kaldor, V. Beek, I. Wodak et al., Epidemiology of hepatitis C virus infection among injecting drug users in Australia., Journal of Epidemiology & Community Health, vol.51, issue.6, pp.692-697, 1997.
DOI : 10.1136/jech.51.6.692

P. Bacchetti, P. Tien, E. Seaberg, O. Brien, T. Augenbraun et al., Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression, BMC Infectious Diseases, vol.38, issue.4, p.145, 2007.
DOI : 10.1016/S0270-9139(03)80154-4

R. Coutinho, HIV and hepatitis C among injecting drug users, BMJ, vol.317, issue.7156, pp.424-425, 1998.
DOI : 10.1136/bmj.317.7156.424

N. Crofts, C. Aitken, and J. Kaldor, The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not, Med J Aust, vol.170, pp.220-221, 1999.

D. Jarlais, D. Diaz, T. Perlis, T. Vlahov, D. Maslow et al., Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City, American Journal of Epidemiology, vol.157, issue.5, pp.467-471, 2003.
DOI : 10.1093/aje/kwf222

J. Emmanuelli and J. Desenclos, Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003, Addiction, vol.91, issue.11, pp.1690-1700, 1996.
DOI : 10.1111/j.1360-0443.2005.01271.x

C. Fuller, D. Ompad, S. Galea, Y. Wu, B. Koblin et al., Hepatitis C Incidence--a Comparison Between Injection and Noninjection Drug Users in New York City, Journal of Urban Health: Bulletin of the New York Academy of Medicine, vol.81, issue.1, pp.20-24, 2004.
DOI : 10.1093/jurban/jth084

A. Judd, M. Hickman, S. Jones, T. Mcdonald, J. Parry et al., Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study, BMJ, vol.330, issue.7481, pp.24-25, 2005.
DOI : 10.1136/bmj.38286.841227.7C

M. Law, G. Dore, N. Bath, S. Thompson, N. Crofts et al., Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001, International Journal of Epidemiology, vol.32, issue.5, pp.717-724, 2001.
DOI : 10.1093/ije/dyg101

K. Page-shafer, J. Hahn, and P. Lum, Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough, AIDS, vol.21, issue.14, pp.1967-1969, 2007.
DOI : 10.1097/QAD.0b013e3282ef7701

M. Jauffret-roustide, J. Emmanuelli, M. Quaglia, F. Barin, P. Arduin et al., Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data???The ANRS-Coquelicot Study, Substance Use & Misuse, vol.32, issue.1, pp.1603-1621, 2006.
DOI : 10.3109/16066359509005236

R. Stern, H. Hagan, C. Lelutiu-weinberger, D. Jarlais, D. Scheinmann et al., The HCV Synthesis Project: Scope, methodology, and preliminary results, BMC Medical Research Methodology, vol.316, issue.Suppl 1, p.62, 2008.
DOI : 10.1136/bmj.316.7125.140

C. Aceijas and T. Rhodes, Global estimates of prevalence of HCV infection among injecting drug users, International Journal of Drug Policy, vol.18, issue.5, pp.352-358, 2007.
DOI : 10.1016/j.drugpo.2007.04.004

P. Bello, A. Toufik, M. Gandilhon, and I. Giraudon, Phénomènes émergents liés aux drogues en Sixième rapport national du dispositif TREND. OFDT. Saint-Denis, 2004.

G. Gadel and C. Nunes, Les toxicomanes suivis dans les structures sanitaires et sociales en novembre 1996, Etudes et Résultats, vol.1, pp.1-6, 1998.

R. Ingold, Etude multicentrique sur les attitudes et les comportements des toxicomanes face aux risques de contamination par le VIH et les virus de l'hépatite. IREP, 1996.

C. Palle and S. Tellier, Les usagers de drogues illicites pris en charge par le système de soins en novembre 1997, Etudes et Résultats, vol.59, pp.1-8, 2000.

P. Ardilly, L. Blanc, and D. , Sampling and weighting a survey of homeless persons: a French example, Survey Methodology, vol.27, pp.109-118, 2001.

R. Magnani, K. Sabin, T. Saidel, and D. Heckathorn, Review of sampling hard-to-reach and hidden populations for HIV surveillance, AIDS, vol.19, issue.Supplement 2, pp.67-72
DOI : 10.1097/01.aids.0000172879.20628.e1

G. Stimson, S. Jones, C. Chalmers, and D. Sullivan, A short questionnaire (IRQ) to assess injecting risk behaviour, Addiction, vol.93, issue.3, pp.337-347, 1998.
DOI : 10.1046/j.1360-0443.1998.9333373.x

C. Semaille, F. Barin, F. Cazein, J. Pillonel, F. Lot et al., Monitoring the Dynamics of the HIV Epidemic Using Assays for Recent Infection and Serotyping among New HIV Diagnoses: Experience after 2 Years in France, The Journal of Infectious Diseases, vol.196, issue.3, pp.377-383, 2007.
DOI : 10.1086/519387

M. Jauffret-roustide, Sciences sociales et épidémiologie: des approches méthodologiques qui se complètent, à propos de la question des pratiques à risque chez les usagers de drogues, Bull Epidemiol Hebd, pp.2-3, 2006.

M. Jauffret-roustide, L. Oudaya, M. Rondy, Y. Kudawu, L. Strat et al., Life trajectory and risk-taking among women drug users, Med Sci, issue.2, pp.111-121, 2008.

D. Ompad, C. Fuller, D. Vlahov, D. Thomas, and S. Strathdee, Lack of Behavior Change after Disclosure of Hepatitis C Virus Infection among Young Injection Drug Users in Baltimore, Maryland, Clinical Infectious Diseases, vol.35, issue.7, pp.783-788, 2002.
DOI : 10.1086/342063

C. Fuller, D. Vlahov, C. Latkin, D. Ompad, D. Celentano et al., Social Circumstances of Initiation of Injection Drug Use and Early Shooting Gallery Attendance: Implications for HIV Intervention Among Adolescent and Young Adult Injection Drug Users, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.32, issue.1, pp.86-93, 2003.
DOI : 10.1097/00126334-200301010-00013

G. Vidal-trecan, I. Varescon-pousson, B. Gagniere, S. Lessenot, E. Madariaga et al., Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users, Ann Med Interne, vol.153, pp.219-225, 2002.

R. Garfein, D. Vlahov, N. Galai, M. Doherty, and K. Nelson, Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses., American Journal of Public Health, vol.86, issue.5, pp.655-661, 1996.
DOI : 10.2105/AJPH.86.5.655

L. Novelli, S. Sherman, J. Havens, S. Strathdee, and M. Sapun, Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users, Drug and Alcohol Dependence, vol.77, issue.3, pp.303-309, 2005.
DOI : 10.1016/j.drugalcdep.2004.08.021

A. Sutton, N. Gay, W. Edmunds, V. Hope, O. Gill et al., Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales, BMC Infectious Diseases, vol.330, issue.1, p.93, 2006.
DOI : 10.1136/bmj.38286.841227.7C

J. Mcmahon, E. Pouget, and S. Tortu, Individual and Couple???Level Risk Factors for Hepatitis C Infection among Heterosexual Drug Users: A Multilevel Dyadic Analysis, The Journal of Infectious Diseases, vol.195, issue.11, pp.1572-1581, 2007.
DOI : 10.1086/516785

E. Roy, N. Haley, P. Leclerc, J. Boivin, L. Cedras et al., Risk factors for hepatitis C virus infection among street youths, CMAJ, vol.165, pp.557-560, 2001.

D. Jarlais, D. Braine, N. Friedmann, and P. , Unstable Housing as a Factor for Increased Injection Risk Behavior at US Syringe Exchange Programs, AIDS and Behavior, vol.27, issue.1, pp.78-84, 2007.
DOI : 10.1007/s10461-007-9227-6

D. Foley, Single-room occupancy hotels: possible solutions and alternatives, Body Posit, vol.11, pp.35-39, 1998.

A. Zolopa, J. Hahn, R. Gorter, J. Miranda, D. Wlodarczyk et al., HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample, JAMA: The Journal of the American Medical Association, vol.272, issue.6, pp.455-461, 1994.
DOI : 10.1001/jama.272.6.455

J. Mcmahon and S. Tortu, A Potential Hidden Source of Hepatitis C Infection Among Noninjecting Drug Users, Journal of Psychoactive Drugs, vol.24, issue.4, pp.455-460, 2003.
DOI : 10.1186/1471-2334-1-8

A. Neaigus, V. Gyarmathy, M. Zhao, M. Miller, and S. Friedman, Sexual and Other Noninjection Risks for HBV and HCV Seroconversions among Noninjecting Heroin Users, The Journal of Infectious Diseases, vol.195, issue.7, pp.1052-1061, 2007.
DOI : 10.1086/512081

S. Faruque, B. Edlin, C. Mccoy, C. Word, S. Larsen et al., Crack Cocaine Smoking and Oral Sores in Three Inner-City Neighborhoods, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.13, issue.1, pp.87-92, 1996.
DOI : 10.1097/00042560-199609000-00012

H. Hagan and H. Thiede, Des Jarlais DC: HIV/hepatitis C virus coinfection in drug users: risk behavior and prevention, AIDS 2005, vol.19, pp.199-207

J. Porter and L. Bonilla, Crack users' cracked lips: an additional HIV risk factor., American Journal of Public Health, vol.83, issue.10, pp.1490-1491, 1993.
DOI : 10.2105/AJPH.83.10.1490-a

T. Fitzgerald, L. Lundgren, and D. Chassler, Factors associated with HIV/AIDS high-risk behaviours among female injection drug users, AIDS Care, vol.161, issue.1, pp.67-74, 2007.
DOI : 10.1016/0149-7189(94)90035-3

B. Leigh and R. Stall, Substance use and risky sexual behavior for exposure to HIV: Issues in methodology, interpretation, and prevention., American Psychologist, vol.48, issue.10, pp.1035-1045, 1993.
DOI : 10.1037/0003-066X.48.10.1035

R. Macrae and E. Aalto, Gendered power dynamics and HIV risk in drug-using sexual relationships, AIDS Care, vol.12, issue.4, pp.505-515, 2000.
DOI : 10.1080/09540120050123909

P. Spittal, K. Craib, E. Wood, N. Laliberte, K. Li et al., Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver, CMAJ, vol.166, pp.894-899, 2002.

C. Berg, . Van-den, C. Smit, M. Bakker, R. Geskus et al., Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users, European Journal of Epidemiology, vol.40, issue.Suppl 5, pp.183-193, 2007.
DOI : 10.1007/s10654-006-9089-7

D. Lucidarme, A. Bruandet, D. Ilef, J. Harbonnier, C. Jacob et al., Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France, Epidemiology and Infection, vol.132, issue.4, pp.699-708, 2004.
DOI : 10.1017/S095026880400247X

D. Jarlais, D. Perlis, T. Arasteh, K. Torian, L. Hagan et al., Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990???2001, AIDS, vol.19, issue.Suppl 3, pp.20-25, 1990.
DOI : 10.1097/01.aids.0000192066.86410.8c

N. Wright and C. Tompkins, A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users, Harm Reduction Journal, vol.3, issue.1, p.27, 2006.
DOI : 10.1186/1477-7517-3-27

C. Van-den-berg, C. Smit, V. Brussel, G. Coutinho, R. Prins et al., Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users, Addiction, vol.361, issue.9, pp.1454-1462, 2007.
DOI : 10.1111/j.1360-0443.2007.01912.x